Swiss National Council Passes Motion to Ban Disposable E-Cigarettes

Jun.13.2024
Swiss National Council Passes Motion to Ban Disposable E-Cigarettes
Swiss Parliament approves motion to ban disposable e-cigarettes sales, citing concerns over youth usage and environmental impact.

According to a report by CDT on June 12th, the Swiss National Council has passed a motion proposed by Christophe Clivaz (Swiss Green Party) to completely ban the sale of disposable e-cigarettes in Switzerland.


The parliamentary bill requires amendments to the federal Tobacco and E-Cigarette Act to prohibit the sale of disposable products, without impacting rechargeable e-cigarettes.


Krivaz pointed out, "The tobacco prevention community and teacher organizations are very concerned about these 'nicotine bombs.' They are attracting young people, and disposable e-cigarettes entered the Swiss market in 2020 and have since become a serious environmental issue. In 2022, around 10 million disposable e-cigarettes were imported into Switzerland, and the number continues to rise.


Federal parliamentarian Elisabeth Baume-Schneider stated that disposable e-cigarettes are very popular among Swiss teenagers aged 15 to 19, with about 8% of teenagers using them at least once a month. She added that the Minister of Health emphasized that the "Federal Tobacco Products and E-Cigarette Act," scheduled to come into effect this autumn, will prohibit the sale of these products to minors and impose restrictions on advertising.


The legislator emphasized that theoretically, the government already has legal grounds to prohibit disposable products in terms of environmental issues. However, in this particular case, it is necessary to examine whether this ban complies with Switzerland's international commitments.


For the current issue, this resolution is premature.


The Swiss National Council voted with 122 in favor, 63 against, and 4 abstentions to approve the proposal. The proposal will now be submitted to the Swiss Federal Council for review.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Russian Vape Industry Proposes State Monopoly on E-Liquid Production as Alternative to Ban
Russian Vape Industry Proposes State Monopoly on E-Liquid Production as Alternative to Ban
Russian business groups are trying to persuade the authorities to abandon plans to ban the sale of e-cigarettes and related liquids at both the federal and regional levels.
Apr.03 by 2FIRSTS.ai
Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 2.988 billion, up 4.57% year on year, while net profit attributable to shareholders turned to a loss of RMB 346 million. In the first quarter of 2026, revenue rose 58.13% year on year to RMB 1.005 billion, but attributable net profit fell 45.16% to RMB 36.5349 million. The company said both revenue and cost growth were related to the expansion of its new tobacco business.
Apr.28 by 2FIRSTS.ai
Azerbaijan Amends Administrative Offenses Code to Penalize E-Cigarette Violations
Azerbaijan Amends Administrative Offenses Code to Penalize E-Cigarette Violations
Azerbaijan has established fines for the import, export, production and sale of e-cigarettes. Under amendments to the Administrative Offenses Code approved by President Ilham Aliyev, using e-cigarettes in places prohibited by the law “On the Restriction of Tobacco Product Use,” including streets and other public areas, will result in a fine of 30 manat.
Mar.16 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Product | Dual-Chamber 20ml E-liquid and 35,000 Puffs: JNR ShishaSip 35K Goes on Sale Online in the Spanish and French Markets
Product | Dual-Chamber 20ml E-liquid and 35,000 Puffs: JNR ShishaSip 35K Goes on Sale Online in the Spanish and French Markets
E-cigarette brand JNR has recently launched its new pod-based device, the JNR ShishaSip 35K, on its official website. The product adopts a dual-chamber structure with two built-in 10ml prefilled pods, bringing total e-liquid capacity to 20ml. It is officially claimed to provide about 35,000 puffs and features a 1050mAh battery, a 0.6Ω mesh coil, a display screen, and adjustable airflow. The product is already on sale through online channels in France and Spain at a price of EUR 15.90.
Apr.10 by 2FIRSTS.ai